Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Baxter International stock in Canada | $79.7

Own Baxter International shares in just a few minutes.

Baxter International Inc is a medical instruments & supplies business based in the US. Baxter International shares (BAX) are listed on the NYSE and all prices are listed in US Dollars. Baxter International employs 50,000 staff and has a trailing 12-month revenue of around USD$12.2 billion.

How to buy shares in Baxter International

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BAX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy Baxter International stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted Baxter International's stock price?

Since the stock market crash in March caused by coronavirus, Baxter International's stock price has had significant negative movement.

Its last market close was $79.7, which is 14.00% down on its pre-crash value of $92.67 and 15.34% up on the lowest point reached during the March crash when the stocks fell as low as $69.1.

If you had bought $1,000 worth of Baxter International stocks at the start of February 2020, those stocks would have been worth $800.68 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $888.66.

Baxter International stock price

Use our graph to track the performance of BAX stocks over time.

Baxter International shares at a glance

Information last updated 2021-10-16.
Latest market close$79.70
52-week range$72.86 - $87.70
50-day moving average $80.57
200-day moving average $81.36
Wall St. target price$94.20
PE ratio 36.5764
Dividend yield $1.015 (1.27%)
Earnings per share (TTM) $2.18

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
OFFER
Wealthsimple Trade
Stocks, ETFs
$0
N/A
$0
Free
Get 2 free stocks when you open a Wealthsimple Trade personal account and deposit and trade at least $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
BMO InvestorLine
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$9.95
$9.95 + $1.25 per options contract
$0 if conditions met, otherwise $25/quarter
$0 - $9.95
Buy and sell a select group of Canada’s most popular ETFs without paying commissions.
An easy-to-use online trading platform with access to research, tools, and the option to access InvestorLine adviceDirect for additional professional support.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$4.99-$9.99
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$0
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$6.95
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95-$9.95
$9.95 + $1 per contract
$0
Free
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
OFFER
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Get up to 50 free trades. Be one of the first 100 new Qtrade clients to use the promo code 50FREETRADES and deposit a minimum of $10,000 (or top up to $15,000 to get $150 transfer fees waived). Valid until December 31, 2021.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.
loading

Compare up to 4 providers

Online stock trading

Baxter International price performance over time

Historical closes compared with the close of $79.7 from 2021-10-15

1 week (2021-10-08) -0.62%
1 month (2021-09-17) -4.68%
3 months (2021-07-16) -2.11%
6 months (2021-04-16) -7.93%
1 year (2020-10-16) -2.59%
2 years (2019-10-18) -9.42%
3 years (2018-10-18) 13.10%
5 years (2016-10-18) 65.83%

Is Baxter International under- or over-valued?

Valuing Baxter International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Baxter International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Baxter International's P/E ratio

Baxter International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, Baxter International shares trade at around 37x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Baxter International's PEG ratio

Baxter International's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4857. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Baxter International's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Baxter International's EBITDA

Baxter International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.8 billion.

The EBITDA is a measure of a Baxter International's overall financial performance and is widely used to measure a its profitability.

Baxter International financials

Revenue TTM $12.2 billion
Operating margin TTM 15.71%
Gross profit TTM $4.7 billion
Return on assets TTM 6.12%
Return on equity TTM 13.55%
Profit margin 9.18%
Book value $16.99
Market capitalisation $39.8 billion

TTM: trailing 12 months

Shorting Baxter International shares

There are currently 7.5 million Baxter International shares held short by investors – that's known as Baxter International's "short interest". This figure is 18.8% up from 6.3 million last month.

There are a few different ways that this level of interest in shorting Baxter International shares can be evaluated.

Baxter International's "short interest ratio" (SIR)

Baxter International's "short interest ratio" (SIR) is the quantity of Baxter International shares currently shorted divided by the average quantity of Baxter International shares traded daily (recently around 3.8 million). Baxter International's SIR currently stands at 1.95. In other words for every 100,000 Baxter International shares traded daily on the market, roughly 1950 shares are currently held short.

However Baxter International's short interest can also be evaluated against the total number of Baxter International shares, or, against the total number of tradable Baxter International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Baxter International's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Baxter International shares in existence, roughly 20 shares are currently held short) or 0.015% of the tradable shares (for every 100,000 tradable Baxter International shares, roughly 15 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Baxter International.

Baxter International's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Baxter International.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Baxter International's total ESG risk score

Total ESG risk: 24.49

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Baxter International's overall score of 24.49 (as at 01/01/2019) is nothing to write home about – landing it in it in the 47th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Baxter International is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Baxter International's environmental score

Environmental score: 1.01/100

Baxter International's environmental score of 1.01 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Baxter International is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Baxter International's social score

Social score: 16.22/100

Baxter International's social score of 16.22 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Baxter International is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Baxter International's governance score

Governance score: 6.28/100

Baxter International's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Baxter International is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Baxter International's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Baxter International scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Baxter International hasn't always managed to keep its nose clean.

Baxter International share dividends

33%

Dividend payout ratio: 32.92% of net profits

Recently Baxter International has paid out, on average, around 32.92% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.41% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Baxter International shareholders could enjoy a 1.41% return on their shares, in the form of dividend payments. In Baxter International's case, that would currently equate to about $1.015 per share.

While Baxter International's payout ratio might seem fairly standard, it's worth remembering that Baxter International may be investing much of the rest of its net profits in future growth.

Baxter International's most recent dividend payout was on 1 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 2 September 2021 (the "ex-dividend date").

Have Baxter International's shares ever split?

Baxter International's shares were split on a 1841:1000 basis on 1 July 2015. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1841 shares. This wouldn't directly have changed the overall worth of your Baxter International shares – just the quantity. However, indirectly, the new 45.7% lower share price could have impacted the market appetite for Baxter International shares which in turn could have impacted Baxter International's share price.

Baxter International share price volatility

Over the last 12 months, Baxter International's shares have ranged in value from as little as $72.8561 up to $87.6993. A popular way to gauge a stock's volatility is its "beta".

BAX.US volatility(beta: 0.61)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Baxter International's is 0.6138. This would suggest that Baxter International's shares are less volatile than average (for this exchange).

Baxter International overview

Baxter International Inc. , through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

Go to site